España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
ACADIA Pharmaceuticals
ACAD
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$16.87
0.14
0.84%
At close: -
$16.81
-0.06
-0.36%
After Hours: Dec 20, 6:00 PM EDT
Get Report
Comment
ACADIA Pharmaceuticals (ACAD) Forecast
News
Earnings
ACADIA Pharmaceuticals (ACAD) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock
ACADIA Pharmaceuticals Stock (NASDAQ: ACAD)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, December 11, 2024
Acadia Pharmaceuticals Announces Closing Of S...
Benzinga Newsdesk
Tuesday, November 26, 2024
Acadia Pharmaceuticals Announces Exclusive Li...
Benzinga Newsdesk
Thursday, November 07, 2024
ACADIA Pharmaceuticals shares are trading hig...
Benzinga Newsdesk
Needham Reiterates Buy on ACADIA Pharmaceutic...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on ACADIA ...
Benzinga Newsdesk
Wednesday, November 06, 2024
Acadia Sees FY24 Revenue $940M-$960M
Benzinga Newsdesk
ACADIA Pharmaceuticals Q3 2024 Adj. EPS $0.20...
Benzinga Newsdesk
Tuesday, November 05, 2024
Acadia Pharmaceuticals Enters Into An Agreeme...
Benzinga Newsdesk
Wednesday, October 16, 2024
Acadia Pharmaceuticals Announces Health Canad...
Benzinga Newsdesk
Thursday, October 10, 2024
Critical Insights From ACADIA Pharmaceuticals Analyst Ratings: What You Need To Know
Benzinga Insights
Raymond James Reinstates Market Perform on AC...
Benzinga Newsdesk
Thursday, September 26, 2024
Notable Insider Move: Owen Catherine Adams Takes Part In Options Exercise At ACADIA Pharmaceuticals
Benzinga Insights
Tuesday, September 24, 2024
What's Going On With ACADIA Pharmaceuticals Stock?
Henry Khederian
ACADIA Pharmaceuticals shares are trading low...
Benzinga Newsdesk
Monday, September 23, 2024
ACADIA Pharmaceuticals shares are trading low...
Benzinga Newsdesk
Acadia Pharmaceuticals Appoints Catherine Owe...
Benzinga Newsdesk
Thursday, September 19, 2024
Axcelead Drug Discovery Partners Enters Into ...
Benzinga Newsdesk
Tuesday, August 27, 2024
Jim Cramer Believes In Dell CEO, Doesn't Like B&G Foods
Avi Kapoor
Wednesday, August 21, 2024
CEO At ACADIA Pharmaceuticals Sells $485K Of Stock
Benzinga Insights
EVP Of ACADIA Pharmaceuticals Sold $145K In Stock
Benzinga Insights
Mark Schneyer Implements A Sell Strategy: Offloads $148K In ACADIA Pharmaceuticals Stock
Benzinga Insights
Thursday, August 15, 2024
Axsome Banks on Auvelity & Sunosi to Fuel Growth
Zacks
Thursday, August 08, 2024
Citigroup Maintains Buy on ACADIA Pharmaceuti...
Benzinga Newsdesk
UBS Maintains Buy on ACADIA Pharmaceuticals, ...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on ACADIA ...
Benzinga Newsdesk
Wednesday, August 07, 2024
Needham Maintains Buy on ACADIA Pharmaceutica...
Benzinga Newsdesk
Cantor Fitzgerald Maintains Overweight on ACA...
Benzinga Newsdesk
RBC Capital Maintains Outperform on ACADIA Ph...
Benzinga Newsdesk
Airbnb Reports Weak Earnings, Joins Cryoport, Tripadvisor, Lyft And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
Expert Outlook: ACADIA Pharmaceuticals Through The Eyes Of 5 Analysts
Benzinga Insights
ACADIA Pharmaceuticals shares are trading low...
Benzinga Newsdesk
Morgan Stanley Downgrades ACADIA Pharmaceutic...
Benzinga Newsdesk
Tuesday, August 06, 2024
Acadia Pharmaceuticals Sees FY24 Total Revenu...
Benzinga Newsdesk
ACADIA Pharmaceuticals Q2 2024 GAAP EPS $0.20...
Benzinga Newsdesk
ACADIA Pharmaceuticals shares are trading low...
Benzinga Newsdesk
Thursday, July 18, 2024
Acadia Pharmaceuticals Announces Continued Im...
Benzinga Newsdesk
Friday, July 12, 2024
A Closer Look at 13 Analyst Recommendations For ACADIA Pharmaceuticals
Benzinga Insights
Morgan Stanley Maintains Overweight on ACADIA...
Benzinga Newsdesk
Thursday, June 27, 2024
This Vertex Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Avi Kapoor
BMO Capital Initiates Coverage On ACADIA Phar...
Benzinga Newsdesk
Tuesday, June 25, 2024
Expert Ratings For ACADIA Pharmaceuticals
Benzinga Insights
RBC Capital Reiterates Outperform on ACADIA P...
Benzinga Newsdesk
Tuesday, June 18, 2024
Acadia Pharmaceuticals Presents DAYBUE Real-W...
Benzinga Newsdesk
Friday, May 24, 2024
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February
Vandana Singh
Friday, May 10, 2024
B of A Securities Maintains Neutral on ACADIA...
Benzinga Newsdesk
Thursday, May 09, 2024
HC Wainwright & Co. Maintains Buy on ACADIA P...
Benzinga Newsdesk
Citigroup Maintains Buy on ACADIA Pharmaceuti...
Benzinga Newsdesk
ACADIA Pharmaceuticals shares are trading low...
Benzinga Newsdesk
Stifel Maintains Hold on ACADIA Pharmaceutica...
Benzinga Newsdesk
Cantor Fitzgerald Reiterates Overweight on AC...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch